Dermaceum Sp. z o.o.

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)6 trials
• Alopecia areata2 trials
• Hidradenitis suppurativa2 trials
• Chronic spontaneous urticaria1 trial
• Psoriasis1 trial
• Vitiligo1 trial

Phase

• Phase 27 trials
• Phase 34 trials
• Phase 11 trial

Status

• Completed4 trials
• Recruiting4 trials
• Active, not recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Amgen Inc.2 trials
• Almirall, S.A.1 trial
• Apogee Therapeutics Inc.1 trial
• Apogee Therapeutics, Inc.1 trial
• Can-Fite BioPharma1 trial
• and 6 more

Running trials

• Recruiting

  A Phase 2 Study of Lesigercept (YH35324) in Adult Patients with Chronic Spontaneous Urticaria (CLEAR)

  2025-524006-14-00· Phase 2· Yuhan Corp.· Source

• Active, not recruiting

  A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

  NCT07277660· Phase 2· UCB Biopharma SRL· Source

• Recruiting

  A Study of LAD603 in Adults With Alopecia Areata

  NCT07311564· Phase 2· Almirall, S.A.· Source

• Recruiting

  A first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy volunteers followed by adults with autoimmune disease.

  2025-521658-40-00· Phase 1· Egle Therapeutics· Source

• Recruiting

  A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis

  2024-519795-11-00· Phase 2· Apogee Therapeutics Inc.· Source

• Not yet recruiting

  A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

  NCT06643260· Phase 3· Can-Fite BioPharma· Source

• Recruiting

  Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

  NCT06855498· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  A Study Evaluating APG777 in Atopic Dermatitis

  NCT06395948· Phase 2· Apogee Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)2 recruiting
• Alopecia areata1 recruiting
• Chronic spontaneous urticaria1 recruiting
• Hidradenitis suppurativa1 recruiting
• Vitiligo1 recruiting

Closed trials

• Terminated

  A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

  NCT06685835· Phase 2· Insmed Incorporated· Source

• Completed

  A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

  NCT06340360· Phase 2· Nektar Therapeutics· Source

• Completed

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· Phase 3· Amgen Inc.· Source

• Completed

  Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO)

  2022-501586-50-00· Phase 3· Amgen Inc.· Source